Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease

Wenli Zhao,Yue Liu,Lijuan Xu,Yuan He,Zhenyu Cai,Jianqiang Yu,Wannian Zhang,Chengguo Xing,Chunlin Zhuang,Zhuo Qu
DOI: https://doi.org/10.1021/acschemneuro.2c00172
2022-01-01
ACS Chemical Neuroscience
Abstract:Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder featured by memory loss and cognitive default. However, there has been no effective therapeutic approach to prevent the development of AD and the available therapies are only to alleviate some symptoms with limited efficacy and severe side effects. Necroptosis is a new kind of cell death, being regarded as a genetically programmed and regulated pattern of necrosis. Increasing evidence reveals that necroptosis is tightly related to the occurrence and development of AD. This review aims to summarize the potential role of necroptosis in AD progression and the therapeutic capacity of targeting necroptosis for AD patients.
What problem does this paper attempt to address?